FDA Drug Application (125268) for NPLATE by AMGEN

Back to FDA Applications sponsored by AMGEN

Application Number125268
Product Number001
FormINJECTABLE; SUBCUTANEOUS
Dosage250MCG/0.5ML; 500MCG/1ML.
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNPLATE
Active IngredientROMIPLOSTIM



Back to FDA Applications sponsored by AMGEN